Blueprint Medicines: Q1 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Blueprint Medicines Corp. (BPMC) on Thursday reported first-quarter net income of $89.1 million, after reporting a loss in the same period a year earlier.

The Cambridge, Massachusetts-based company said it had profit of $1.40 per share. Losses, adjusted to extinguish debt, were $1.32 per share.

The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.64 per share.

The cancer drug developer posted revenue of $96.1 million in the period, also topping Street forecasts. Nine analysts surveyed by Zacks expected $82.6 million.

Blueprint Medicines shares have increased 3% since the beginning of the year. The stock has increased 84% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BPMC at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up